Investigation of the thiol-disulfide system state of rats with encephalopathy caused by the effect of antituberculous drugs
DOI:
https://doi.org/10.14739/2310-1237.2019.3.188799Keywords:
resistance tuberculosis, anti-tuberculosis drugs, adverse drug reactions, neurotoxicity, glutathioneAbstract
Objective. To determine in an experimental study the nature of changes in the status of the thiol-disulfide system of rats with encephalopathy, due to the influence of complex of anti-tuberculosis drugs for the treatment of chemoresistant tuberculosis and the possibility of their drug correction with the use of ademetionine 1,4-butanedisulfonate.
Materials and methods. The study was conducted on 30 Wistar rats, which were divided into 3 groups: 10 – intact group, 10 – control group (treated with antituberculosis drugs) and 10 – main group (treated with antituberculosis drugs and ademetionine as means of correcting toxic effects). The state of the glutathione system and the content of homocysteine and nitrotyrosine were investigated.
Results. Experimental therapy with ademetionine in rats treated with antituberculosis drugs helps to reduce the intensity of chronic oxidative stress in nerve tissue. The introduction of ademetionine establishes the most optimal ratio between the levels of reduced and oxidized thiol groups, as well as glutathione, which indicates the active mobilization of the thiol-disulfide system and the neutralization of products of free-radical oxidation. Under the conditions of nitrosative and oxidative stress, the studied agents increase the resistance of nervous tissue to the manifestations of intoxication. Thus, one of the links of the neuroprotective effect of ademetionin was its ability to stabilize the thiol-disulfide equilibrium.
Conclusions. In the functioning of the glutathione-dependent enzymatic system in the tissues of the brain of rats treated with anti-tuberculosis drugs, there was decreased activity of glutathione s-transferase, glutathione peroxidase and glutathione reductase by 2.0, 1.7 and 2.4 times, respectively. Under the conditions of ademetionin therapy, there was increase by 1.7 times in the reduced intermediates of the thiol-disulfide system – SH-group, and an increase of the level of reduced glutathione by 1.9 times, against the background of a significant decrease in the content of its oxidized form – 1.4 times. The use of ademetionin also led to a decrease of the content of potentially neurotoxic compounds - nitrotyrosine and homocysteine by 1.4 and 1.5 times, respectively in the brain tissues, which increases the resistance of nervous tissue to the effects of intoxication.
References
Belenichev, I. F., & Kucher, T. V. (2016). Deprivatsiya glutationovoi sistemy v tsitozole i mitokhondriyakh golovnogo mozga krys s khronicheskoi alkogol'noi intoksikatsiei: zashchitnye effekty tiol'nykh antioksidantov [The deprivation of glutathione system in the cytosol and mitochondria of rat brain with chronic alcohol intoxications: protective effects of thiol antioxidants]. Visnyk problem biolohii i medytsyny, 4(1), 111-116. [in Russian].
Belenichev, I. F., & Gorbacheva, S. V. (2015). Antioksidantnaya modulyatsiya neiroapoptoza v usloviyakh disbalansa tiol-disul'fidnoi sistemy i nakopleniya okislennykh promezhutochnykh soedinenii in vitro [Antioxidant Neyroapoptosis Modulation Unbalance in a Thiol-Disulfide System and the Accumulation of Oxidized Intermediates in vitro]. Visnyk problem biolohii i medytsyny, 3(1), 24-128. [in Russian].
Аbdullаev, R. Y., Komissаrovа, O. G., Chumаkovа, E. S., Odinets, V. S., & Ergeshov, A. E. (2019). Gepatotoksicheskie reaktsii pri lechenii vpervye vyyavlennykh bol'nykh tuberkulezom legkikh s mnozhestvennoi lekarstvennoi ustoichivost'yu vozbuditelya [Hepatotoxic reactions during treatment of newly diagnosed patients with pulmonary multiple drug resistant tuberculosis]. Tuberkulez i bolezni legkikh, 97(7), 21-27. [in Russian]. https://doi.org/10.21292/2075-1230-2019-97-7-21-27
Ivаnovа, D. A., & Borisov, S. E. (2017). Spektr i faktory riska nezhelatel'nykh pobochnykh reaktsii pri lechenii vpervye vyyavlennykh bol'nykh tuberkulezom [Profile and risk factors of adverse reactions in new tuberculosis cases receiving treatment]. Tuberkulez i bolezni legkikh, 95(6), 22-29. [in Russian]. https://doi.org/10.21292/2075-1230-2017-95-6-22-29
Bielenichev, I. F., Vіzіr, V. A., Mamchur, V. Y., & Kuriata, O. V. (2019). Mesto tiotriazolina v galeree sovremennykh metabolitotropnykh lekarstvennykh sredstv [Place of tiotriazoline in the gallery of modern metabolitotropic medicines]. Zaporozhye Medical Journal, 21(1), 118-128. [in Russian]. https://doi.org/10.14739/2310-1210. 2019.1.155856
Belenichev, I. F., Chernii, V. I., Nagornya, E. A., Pavlov, S. V., Buhtiyarova, N. V., Chernii, T. V., & Gorchakova, N. A. (2014). Neiroprotektsiya i neiroplastichnost' [Neuroprotection and neuroplasticity]. Kiеv: Logos [in Russian].
Gubergric, N. B., Fomenko, P. G., Golubova, O. A., Lukashevich, G. M., Belyaeva, N. V., & Agibalov, A. N. (2014). "Rokovaja cepochka" i ademetionin ["Fatal chain" and ademetionine]. Suchasna hastroenterolohiya, 4, 106-120. [in Russian].
Todoriko L. D., Petrenko V. I., & Shevchenko O. S. (2016). Perspektyvy podolannia tuberkulozu v Ukraini. [Prospects for overcoming tuberculosis in Ukraine]. Tuberkulioz, lehenevi khvoroby, VIL-infektsiia, 1, 72-78. [in Ukrainian].
Lytvynenko, N. A., Varytska, H. A., Grankina, N. V., Chobotar, O. P., & Senko, Yu. O. (2017). Faktory neeffektivnogo lecheniya u bol'nykh s mul'tirezistentnym tuberkulezom i tuberkulezom s shirokoi lekarstvennoi rezistentnost'yu [Factors of unfavorable treatment outcomes in patients with multidrug resistant tuberculosis and extensively drug resistant tuberculosis]. The scientific heritage, 10, 24-32. [in Russian].
Usov, K. I., Gusʹkova, T. A., Jushkov, G. G., Grishina, L. P., & Gushchin, A. S. (2018). Eksperimental'noe obosnovanie terapii soprovozhdeniya s primeneniem ademetionina dlya snizheniya gepatotoksicheskikh reaktsiĭ protivotuberkuleznykh preparatov [Experimental justification of supportive therapy with ademetionine for the reduction of hepatotoxic reactions to antituberculosis drugs]. Toksikologicheskii vestnik, 6, 12-21. https://doi.org/10.36946/0869-7922-2018-6-12-21
Aquilano, K., Baldelli, S., & Ciriolo, M. R. (2014). Glutathione: new roles in redox signaling for an old antioxidant. Frontiers in Pharmacology, 5, Article 196. https://doi.org/10.3389/fphar.2014.00196
Belenichev, I. F., Gorbacheva, S. V., Demchenko, A. V., & Bukhtiyarova, N. V. (2014). The thiol-disulfide balance and the nitric oxide system in the brain tissue of rats subjected to experimental acute impairment of cerebral blood flow: The therapeutic effects of nootropic drugs. Neurochemical Journal, 8(1), 24-27. https://doi.org/10.1134/s181971241401005x
Dela, A. I., Tank, N. K. D., Singh, A. P., & Piparva, K. G. (2017). Adverse drug reactions and treatment outcome analysis of DOTS-plus therapy of MDR-TB patients at district tuberculosis centre: A four year retrospective study. Lung India, 34(6), 522-526. https://doi.org/10.4103/0970-2113.217569
Fan, G.-R., Yin, Z.-D., Sun, Y., Chen, S., Zhang, W.-J., Huang, X., Kong, W.-J., & Zhang, H.-L. (2013). Reversible neurotoxicity of kanamycin on dorsal cochlear nucleus. Brain Research, 1502, 30-46. https://doi.org/10.1016/j.brainres.2012.12.049
Gregoire, S., Millecamps, M., Naso, L., Do Carmo, S., Cuello, A. C., Szyf, M., & Stone, L. S. (2017). Therapeutic benefits of the methyl donor S-adenosylmethionine on nerve injury-induced mechanical hypersensitivity and cognitive impairment in mice. Pain, 158(5), 802-810. https://doi.org/10.1097/j.pain.0000000000000811
Kass, J. S., & Shandera, W. X. (2010). Nervous System Effects of Antituberculosis Therapy. Cns Drugs, 24(8), 655-667. https://doi.org/10.2165/11534340-000000000-00000
Mazzei, D., Accardo, J., Ferrari, A., & Primavera, A. (2012). Levofloxacin neurotoxicity and non-convulsive status epilepticus (NCSE): A case report. Clinical Neurology and Neurosurgery, 114(10), 1371-1373. https://doi.org/10.1016/j.clineuro.2012.03.029
Sawant, N. S., Kate, N. S., Bhatankar, S. S., & Kulkarni, P. S. (2015). Neuroleptic malignant syndrome in cycloserine-induced psychosis. Indian Journal of Pharmacology, 47(3), 328-329. https://doi.org/10.4103/0253-7613.157134
Shea, T. B. (2007). Effects of dietary supplementation with N-acetyl cysteine, acetyl-L-carnitine and S-adenosyl methionine on cognitive performance and aggression in normal mice and mice expressing human ApoE4. Neuromolecular Medicine, 9(3), 264-269. https://doi.org/10.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
